Skip to main content
logo
BioRestorative Therapies, Inc. (BRTX)
NASDAQ: BRTX · Real-Time Price · USD
0.2047
-0.0208 (-9.22%)
At close: Jul 31, 2026, 4:00 PM EDT
0.2055
+0.0008 (0.39%)
After-hours: Jul 31, 2026, 7:47 PM EDT

BioRestorative Therapies Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.360.360.40.150.120.05
Revenue Growth
-8.47%-10.30%175.03%21.70%160.44%-40.26%
Gross Profit
0.330.340.370.150.120.05
Operating Income
-14.55-15.98-11.93-15.37-19.09-26.35
Net Income
-11.06-14.24-8.98-10.42-13.22-44.3
Earnings Per Share
-1.07-1.58-1.16-2.47-3.65-37.30
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
3.592.9510.7311.0714.7521.03
Total Debt
0000.160.30.67
Net Cash (Debt)
3.592.9510.7310.914.4520.36
Net Cash Growth
-60.58%-72.49%-1.57%-24.53%-29.03%-
Net Cash Per Share
0.320.331.382.583.9917.14

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-11.82-10.79-8.23-6.43-5.91-3.33
Capital Expenditures
-0.08-0.12-0.11-0.17-0.27-0.03
Free Cash Flow
-11.9-10.91-8.34-6.6-6.18-3.36
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
92.09%93.37%93.00%100.00%100.00%100.00%
Operating Margin
-4067.09%-4443.42%-2974.59%-10539.50%-15938.10%-57291.00%
Pretax Margin
-2296.19%-3662.13%-1689.90%-3950.91%-25540.30%20949.94%
Profit Margin
-2296.19%-3662.13%-1689.90%-3950.91%-25540.30%20949.90%
FCF Margin
-3324.57%-3031.70%-2078.94%-4527.61%-5157.20%-7305.58%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
14.5729.0024.6856.1784.42332.14